NANOFOL - Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases
Abstract
NANOFOL proposes to develop a new diagnostic/therapy approach using folate based nanobiodevices (FBN) able to provide a new type of cost efficient treatment for chronic inflammatory diseases such as Rheumatoid Arthritis with low side effects that will constitute a more advantageous solution than current therapies. These drug delivery devices are primariliy based on functionalized proteines.
Proteine capsules
Publikationen
Project staff
Georg Gübitz
Univ.Prof. Dipl.-Ing. Dr.techn. Georg Gübitz
guebitz@boku.ac.at
Tel: +43 1 47654-97001, 97402
BOKU Project Leader
01.01.2013 - 30.11.2013
Alexandra Herrero-Rollett
Dipl.-Ing. Dr. Alexandra Herrero-Rollett
Project Staff
01.01.2013 - 30.11.2013
BOKU partners
External partners
INSERM U419-Nantes, Institut de Biologie
Tiphaine Guida
partner
Netherlands Organisation for Applied Scientific Research
Dr. Herman Lenting
partner
ALMA Consulting Group S.A.
Julie Chefdebien
partner
INERIS - Institut National de l'Environnement Industriel et des Risques
Vincent Lafleche
partner
SYNOVO GmbH
Michael Burnet
partner
"Aurel Vlaicu" University of Arad
Florentina-Daniela Munteanu
partner
Alfama - Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda.
Carlos Romao
partner
Institute for Molecular and Cell Biology
Dr. Claudia Ferreira
partner
SUAN FARMA S.A.
Hector Ara
partner
EXBIO Praha a.s.
Miloslav Suchanek
partner
UMinho - University of Minho
Artur Cavaco-Paulo
coordinator
Med Uni Wien
Prof. Hannes Stockinger
partner